January 9, 2023
Life Sciences
  • Moderna Inc. said it pulled in $18.4 billion in COVID-19 vaccine sales last year, hitting its 2022 revenue forecast for the products. The company forecasted a minimum of $5 billion of sales this year. (Article here)